Form 10-K for the Year Ended December 31, 2023
We note that throughout the results of operations section in MD&A you discuss the changes in sales by referring to the term "core sales." Please revise future filings to define "core sales" prior to its use in your discussion.
The Company respectfully acknowledges the Staff’s comment and will revise future filings to define “core sales” as the following: Change in sales excluding the impact of foreign currency translation, acquisitions, and divestitures.Read in the reply
First report after the company's reply of May 31, 2024: 10-Q filed Jul 31, 2024 ↗, against the 10-Q filed May 1, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note that in your statement of cash flows, the reconciliation of net income to net cash flows from operations begins with the amount of “net income from continuing operations attributable to common shareholders,” which is a different from net income.Rest of the question
Please note that ASC 230-10-45-28 and 45-29 require that whether or not cash flows from discontinued operations are presented separately in the statement of cash flows, the reconciliation of net income to net cash flows from operations should begin with net income. Please revise future filings accordingly.
The Company respectfully acknowledges the Staff’s comment and in future filings and beginning with the Company’sRead in the reply
Form 10-Q for the quarter ended June 30, 2024, we will revise the Consolidated Statements of Cash Flows to begin the reconciliation of net income to net cash flows from operations with net income.Rest of the answer
Please find the below presentation of our intended disclosure to be included in future filings using the Consolidated Statements of Cash Flows for the year ended December 31, 2023 for illustrative purposes.
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the year ended December 31,
(in millions)
2023
2022
2021
Operating activities:
Net income attributable to common shareholders
$
255.9
401.1
435.4
Less: Income from discontinued operations, net of tax
52.1
229.5
238.0
Net income from continuing operations attributable to common shareholders
203.8
171.6
197.4
Non-cash loss on divestiture of asbestos-related assets and liabilities
—
148.9
Gain on sale of business
(232.5
)
Gain on sale of property
(2.8
(18.5
Depreciation and amortization
39.3
39.5
38.4
Stock-based compensation expense
26.1
21.3
21.7
Defined benefit plans and postretirement cost (credit)
9.3
(1.0
(6.7
Deferred income taxes
(21.5
0.8
(4.9
Cash used for operating working capital
(49.5
(30.3
30.1
Defined benefit plans and postretirement contributions
(18.3
(19.0
(26.9
Environmental payments, net of reimbursements
(3.9
(5.8
Asbestos related payments, net of insurance recoveries
(29.3
(44.9
Divestiture of asbestos-related assets and liabilities
(550.0
Other
8.3
16.4
5 .2
Total provided by (used for) operating activities from continuing operations
193.6
(472.2
First report after the company's reply of May 31, 2024: 10-Q filed Jul 31, 2024 ↗, against the 10-Q filed May 1, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note your response to our prior comment 1 that you will revise to define core sales as "change in sales excluding the impact of foreign currency translation, acquisitions, and divestitures." However, we believe that core sales and core sales growth should be identified as non-GAAP financial measures and the disclosures required by Item 10(e) of Regulation S-K, such as the reconciliation to the most comparableRest of the question
GAAP measure, should be provided when the measures are disclosed in your filings. Please revise future filings accordingly.
The Company respectfully acknowledges the Staff’s comment. The Company does not present core sales for any period but rather discusses core sales as a reason for the year-over-year GAAP net sales change. By way of reference, on page 23 of the Form 10-K for the Year Ended December 31, 2023, the Company provides the components of sales growth including impacts from the core business, foreign exchange and acquisitions/dispositions.Read in the replyRest of the answer
Accordingly, we do not believe that core sales or core sales growth as currently described in our filings as performance metrics should be identified as non-GAAP financial measures and would not require the disclosures in Item 10(e) of Regulation
S-K. However, as noted in our response to the Staff’s comment letter dated May 31, 2024, we will define the term core sales when used in future filings, including Forms
10-K, 10-Q, and the earnings release filed as an exhibit to Form 8-K. In addition, we will ensure that core sales and core sales growth are presented with appropriate prominence in relation to the most comparable GAAP measure (Net sales and Net sales growth) when presented discretely.
First report after the company's reply of Jun 12, 2024: 10-Q filed Jul 31, 2024 ↗, against the 10-Q filed May 1, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: closing letter, 2024-06-13